BCLI target price at $6.35 +24%

Aggiornato
Brainstorm Cell Therapeutics has activated a falling wedge with price target at $6.35 +24% from current price and also deactivated a second bearish impulse.
Trade chiuso: obiettivo raggiunto
BCLIbclilongWedge

Anche su:

Declinazione di responsabilità